StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CNBX Pharmaceuticals's profit margin for the twelve months ending Nov 30, 2024 was -1356.0%. For fiscal 2024 it was -534.5%, against -904.6% the year before. The highest annual figure on record is 11510.4% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Aug 31, 2024-534.5%+370.1
FY2023Aug 31, 2023-904.6%+11523.7
FY2022Aug 31, 2022-12428.2%+91909.7
FY2020Aug 31, 2020-104337.9%−115848.3
FY2019Aug 31, 201911510.4%+50846.1
FY2018Aug 31, 2018-39335.7%−5313.1
FY2017Aug 31, 2017-34022.5%−33749.5
FY2016Aug 31, 2016-273.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2024CQ1 2024Feb 29, 2024-800.9%+800.4
Q1 FY2024CQ4 2023Nov 30, 2023-199.6%+32955.3
Q4 FY2023CQ3 2023Aug 31, 2023-573.6%+37903.4
Q3 FY2023CQ2 2023May 31, 2023-49.9%+66199.4
Q4 FY2022CQ3 2022Aug 31, 2022-1601.3%+291568.3
Q4 FY2020CQ3 2020Aug 31, 2020-33154.9%+34545.4
Q3 FY2020CQ2 2020May 31, 2020-38476.9%−13132.1
Q2 FY2020CQ1 2020Feb 29, 2020-66249.2%−227010.7
Q1 FY2020CQ4 2019Nov 30, 2019-293169.6%−273321.7
Q4 FY2019CQ3 2019Aug 31, 2019-67700.3%−42927.9
Q3 FY2019CQ2 2019May 31, 2019-25344.9%+4146.8
Q2 FY2019CQ1 2019Feb 28, 2019160761.5%+245436.1
Q1 FY2019CQ4 2018Nov 30, 2018-19848.0%+10726.8
Q4 FY2018CQ3 2018Aug 31, 2018-24772.4%+13663.1
Q3 FY2018CQ2 2018May 31, 2018-29491.7%−13869.3
Q2 FY2018CQ1 2018Feb 28, 2018-84674.7%−49413.2
Q1 FY2018CQ4 2017Nov 30, 2017-30574.7%−30437.7
Q4 FY2017CQ3 2017Aug 31, 2017-38435.5%–
Q3 FY2017CQ2 2017May 31, 2017-15622.4%–
Q2 FY2017CQ1 2017Feb 28, 2017-35261.5%–
Q4 FY2016CQ3 2016Aug 31, 2016-137.0%–

More CNBX Pharmaceuticals figures

See a number that looks wrong?